Benchaphorn Limcharoen

Dr. Benchaphorn Limcharoen

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
BLBenchaphorn Limcharoen
Benchaphorn Limcharoen
PTPattrawadee Toprangkobsin
Pattrawadee Toprangkobsin
MKMarius Kröger
Marius Kröger
Maxim DarvinMaxim Darvin
Maxim Darvin
TSTitiporn Sansureerungsikul
Titiporn Sansureerungsikul
Alexa PatzeltAlexa Patzelt
Alexa Patzelt
Topical retinoid treatments stimulate biological activities in the skin. The main physical barrier, which limits the efficacy of transdermal drug delivery, is the stratum corneum. Proretinal nanoparticles (PRN) have already been proven to efficiently deliver retinal into the epidermis. In the present study, two transdermal drug delivery systems, microneedles (MN) and PRN, were combined to directly target the dermis. The microchannels induced by the MN, the PRN localization in the microchannels and the skin closure kinetics were investigated by non-invasive imaging techniques, such as dermoscopy, optical coherence tomography and multiphoton tomography. Additionally, the amount of retinal in the epidermis and dermis after application in three different forms (PRN-Loaded microneedles, PRN suspension or conventional retinal solution) was compared. All imaging techniques confirmed the formation of microchannels in the skin, which were partly still detectable after 24 h. Multiphoton tomography showed the release of PRN from the MN within the microchannels. The recovered retinal concentration in the dermis was significantly higher when applied via PRN-loaded microneedles. We hypothesized that this platform of PRN-loaded microneedles can provide a rapid and efficient administration of retinal in the dermis and could be of benefit in some skin conditions such as atrophic scar or photo-aged skin.

22 April 2024 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
BLBenchaphorn Limcharoen
Benchaphorn Limcharoen
SWSupason Wanichwecharungruang
Supason Wanichwecharungruang
MKMarius Kröger
Marius Kröger
TSTitiporn Sansureerungsikul
Titiporn Sansureerungsikul
JSJohannes Schleusener
Johannes Schleusener
Maxim DarvinMaxim Darvin
Maxim Darvin

26 November 2024 in Advanced Drug Delivery Reviews
Verified
Journal Article
Open access
BLBenchaphorn Limcharoen
Benchaphorn Limcharoen
SWSupason Wanichwecharungruang
Supason Wanichwecharungruang
WBWijit Banlunara
Wijit Banlunara
Maxim DarvinMaxim Darvin
Maxim Darvin
Optical methods play a pivotal role in advancing transdermal drug delivery research, particularly with the emergence of microneedle technology. This review presents a comprehensive analysis of optical methods used in studying transdermal drug delivery facilitated by microneedle technology. Beginning with an introduction to microneedle technology and skin anatomy and optical properties, the review explores the integration of optical methods for enhanced visualization. Optical imaging offers key advantages including real-time drug distribution visualization, non-invasive skin response monitoring, and quantitative drug penetration analysis. A spectrum of optical imaging modalities ranging from conventional dermoscopy and stereomicroscopy to advance techniques as fluorescence microscopy, laser scanning microscopy, in vivo imaging system, two-photon microscopy, fluorescence lifetime imaging microscopy, optical coherence tomography, Raman microspectroscopy, laser speckle contrast imaging, and photoacoustic microscopy is discussed. Challenges such as resolution and depth penetration limitations are addressed alongside potential breakthroughs and future directions in optical techniques development. The review underscores the importance of bridging the gap between preclinical and clinical studies, explores opportunities for integrating optical imaging and chemical sensing methods with drug delivery systems, and highlight the importance of non-invasive "optical biopsy" as a valuable alternative to conventional histology. Overall, this review provides insight into the role of optical methods in understanding transdermal drug delivery mechanisms with microneedles.

25 December 2024 in Poultry Science
Verified
Journal Article
Open access
TNTeerawut Nedumpun
Teerawut Nedumpun
KRKanana Rungprasert
Kanana Rungprasert
PNPatchareeporn Ninvilai
Patchareeporn Ninvilai
BLBenchaphorn Limcharoen
Benchaphorn Limcharoen
WTWikanda Tunterak
Wikanda Tunterak
ATAunyaratana Thontiravong
Aunyaratana Thontiravong
Duck Tembusu virus (DTMUV), an emerging avian pathogenic flavivirus, is notably associated with neurological disorders and acute egg drop syndrome in ducks. We previously demonstrated that the susceptibility of ducks to DTMUV infection varies significantly with age, with younger ducks (4-week-old) exhibiting more severe disease than older ducks (27-week-old). However, the immunological mechanisms underlying these age-related differences in disease severity remain unclear. In this study, we investigated the dynamics of immune responses following DTMUV infection in adult laying ducks (27-week-old) and compared them to our previous findings on young ducks (4 weeks old). The numbers of T helper, cytotoxic T, B, and non-T and B lymphocytes, as well as neutralizing antibody levels, were measured in parallel with DTMUV loads in the blood and target organs. Our results revealed that the number of non-T and B lymphocytes/myeloid cells in 27-week-old adult laying ducks infected with DTMUV remained consistently stable throughout the observation period, in contrast to findings in 4-week-old younger ducks, where myeloid cell responses were implicated in disease progression. Regarding lymphocyte responses, unlike in 4-week-old younger ducks, only cytotoxic T lymphocyte responses in 27-week-old older ducks showed a significant negative correlation with the reduction of viremia and viral loads in target organs, indicating their role in controlling viral replication in older ducks. Additionally, 27-week-old adult laying ducks infected with DTMUV exhibited high levels of neutralizing antibodies, which were significantly correlated with reduced viral loads in blood and target organs. Overall, the presence of robust DTMUV-specific neutralizing antibody and CTL responses, along with a finely tuned myeloid cell response likely plays a significant role in controlling severe neurological outcomes in 27-week-old adult laying ducks. This study highlights the age-related differences in immune responses following DTMUV infection, which potentially contribute to the varying disease severity among ducks of different ages. Understanding the interplay between the host and DTMUV provides significant implications for disease management strategies and vaccine development.

1 January 2025 in Transboundary and Emerging Diseases
Verified
Journal Article
Open access
TNTeerawut Nedumpun
Teerawut Nedumpun
KRKanana Rungprasert
Kanana Rungprasert
BLBenchaphorn Limcharoen
Benchaphorn Limcharoen
ATAunyaratana Thontiravong
Aunyaratana Thontiravong
Duck Tembusu virus (DTMUV) is an emerging avian pathogenic flavivirus that causes neurological disorders and acute egg drop syndrome in ducks. Multiple genotypes of DTMUV, including clusters 1, 2, and 3, have been identified, and recent evidence suggests a correlation between viral genotype and disease severity. Our recent study demonstrated that DTMUV cluster 2.1 induces more severe clinical disease in ducks than cluster 1; however, the underlying mechanisms responsible for this difference remain unclear. Macrophages are key target cells for DTMUV replication and play a crucial role during the early stage of viral pathogenesis. Therefore, we hypothesized that distinct DTMUV genotypes may differentially regulate macrophage apoptosis, thereby influencing viral replication and modulating T lymphocyte responses. To investigate this, we developed an in vitro protocol to generate duck monocyte‐derived macrophages (MDMs) and assessed their response to infection with two different DTMUV genotypes: cluster 1 and cluster 2.1. Our results showed that DTMUV cluster 1 infection significantly increased macrophage apoptosis and reduced cell viability. In contrast, DTMUV cluster 2.1‐infected MDM exhibited higher cell viability and fewer apoptotic cells. Correspondingly, viral titers in supernatants from DTMUV cluster 2.1‐infected cultures were significantly higher than those from cluster 1. Furthermore, culture with DTMUV cluster 2.1 resulted in enhanced proliferation of Th (CD3 + CD4 + BrdU + ) and cytotoxic T lymphocyte (CTL; CD3 + CD8 + BrdU + ) lymphocytes in both naïve peripheral blood mononuclear cells (PBMCs) and macrophage‐peripheral blood lymphocytes (PBLs) co‐culture systems. These results suggest that the inhibition of apoptosis in DTMUV cluster 2.1‐infected macrophages may enhance antigen‐specific T lymphocyte responses. Overall, our findings reveal a genotype‐dependent mechanism by which DTMUV modulates macrophage survival, thereby influencing both viral replication and T cell activation, and ultimately contributing to genotype‐specific immunopathogenesis. These insights deepen our understanding of DTMUV immunopathogenesis and may inform the development of more effective genotype‐targeted vaccination and disease control strategies.

16 September 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KSKittipat Supchukun
Kittipat Supchukun
TYTeerapong Yata
Teerapong Yata
JYJakarwan Yostawonkul
Jakarwan Yostawonkul
BLBenchaphorn Limcharoen
Benchaphorn Limcharoen
SSSayamon Srisuwatanasagul
Sayamon Srisuwatanasagul
Background/Objectives: Canine superficial pyoderma is one of the most common dermatological diseases in dogs and is increasingly complicated by antimicrobial resistance. This study aimed to develop ethyl lauroyl arginate-integrated lipid-based nanoparticles (LAE-LBNs) as a non-antibiotic topical delivery platform and to evaluate their physicochemical stability, skin localization, and antimicrobial activity against clinically relevant canine skin pathogens. Methods: LAE-LBNs were prepared using high-shear homogenization followed by probe ultrasonication and characterized for particle size, polydispersity index, zeta potential, morphology, encapsulation efficiency, and storage stability. Antimicrobial activity was evaluated against methicillin-susceptible Staphylococcus pseudintermedius (MSSP), methicillin-resistant S. pseudintermedius (MRSP), and Malassezia pachydermatis. The ex vivo distribution of Nile Red-labeled formulations was assessed in porcine ear skin using fluorescence microscopy. Results: The optimized 5% LAE-LBN formulation exhibited a relatively small particle size, narrow size distribution, strongly positive surface charge (+46.49 mV), encapsulation efficiency exceeding 99%, and favorable physicochemical stability over two months. Fluorescence associated with the labeled LAE-LBN formulation was observed in the stratum corneum, viable epidermis, and hair follicles, whereas the aqueous control formulation was predominantly confined to the stratum corneum. LAE-LBNs exhibited bactericidal and fungicidal activity against MSSP, MRSP, and M. pachydermatis, with an MBC or MFC of 12.2 µg/mL. These endpoints were identical to those obtained for aqueous LAE, indicating that incorporation into the lipid-based nanocarrier preserved the antimicrobial activity of LAE. Conclusions: LAE-LBNs combined favorable physicochemical properties, follicular localization, and activity against bacterial and fungal canine skin pathogens. These findings support their further investigation as a non-antibiotic topical delivery platform for canine superficial pyoderma.